Business Context and Reporting Period
This Form 8-K Current Report was filed by Dow Inc. and The Dow Chemical Company on January 30, 2024. The filing serves an administrative purpose to submit specific documents as exhibits to the Annual Report on Form 10-K for the fiscal year ended December 31, 2023, thereby avoiding an increase in the size of the 10-K filing.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing regarding exhibit incorporation rather than a financial results report.
Material Changes
No material changes to financial performance or operations are reported in this document. The filing references the restatement and effectiveness of several executive compensation and retirement plans as of January 1, 2024, including:
- The Dow Chemical Company Executives' Supplemental Retirement Plan (Restricted and Cadre Benefits).
- The Dow Chemical Company Executives' Supplemental Retirement Plan (Supplemental Benefits).
- The Dow Chemical Company Elective Deferral Plan (Post 2004).
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, or discussion of unusual items. It strictly lists the incorporation of exhibits related to securities descriptions and stock incentive plan agreements (Performance Stock Units, Restricted Stock Units, Stock Appreciation Rights, and Stock Options) effective as of December 13, 2023.
Investor Verification Checklist
- Verify the full text of the Form 10-K for the year ended December 31, 2023 to obtain actual financial results and comprehensive risk disclosures.
- Review the specific terms of the 2019 Stock Incentive Plan agreements (Exhibits 10.5.8 through 10.5.11) for details on executive compensation structures.
- Confirm the details of the restated executive retirement plans (Exhibits 10.6, 10.7, and 10.9) effective January 1, 2024.